Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
IPO Date: October 7, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $122.36M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 3.17%
Avg Daily Range (30 D): $0.04 | 3.26%
Avg Daily Range (90 D): $0.06 | 3.07%
Institutional Daily Volume
Avg Daily Volume: .67M
Avg Daily Volume (30 D): .86M
Avg Daily Volume (90 D): .79M
Trade Size
Avg Trade Size (Sh.): 156
Avg Trade Size (Sh.) (30 D): 173
Avg Trade Size (Sh.) (90 D): 150
Institutional Trades
Total Inst.Trades: 1,171
Avg Inst. Trade: $1.56M
Avg Inst. Trade (30 D): $1.65M
Avg Inst. Trade (90 D): $1.08M
Avg Inst. Trade Volume: .13M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.48M
Avg Closing Trade (30 D): $2.52M
Avg Closing Trade (90 D): $2.06M
Avg Closing Volume: 127.61K
       
News
Apr 29, 2025 @ 11:00 AM
Aclaris Therapeutics Appoints Jesse Hall, M.D. as ...
Source: N/A
Mar 3, 2025 @ 6:00 PM
JAK Inhibitors Clinical Trial Pipeline Appears Rob...
Source: Delveinsight
Sep 10, 2024 @ 11:00 AM
Aclaris Therapeutics to Participate in the 2024 Ca...
Source: N/A
Jul 23, 2024 @ 11:31 AM
Aclaris Therapeutics And 3 Other Stocks Under $2 I...
Source: Avi Kapoor
Jul 8, 2024 @ 1:01 PM
Aclaris Therapeutics And 1 Other Stock Under $5 In...
Source: Avi Kapoor
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-1.71 $-1.21 $-1.71
Diluted EPS $-1.71 $-1.21 $-1.71
Revenue $ 18.72M $ 9.21M $ 18.72M
Gross Profit $ 15.93M $ 8.51M $ 15.93M
Net Income / Loss $ -132.07M $ -96.55M $ -132.07M
Operating Income / Loss $ -141.93M $ -99.68M $ -141.93M
Cost of Revenue $ 2.79M $ .71M $ 2.79M
Net Cash Flow $ -15.31M $ -23.08M $ -15.31M
PE Ratio